MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

summitplc-logo_05fd32df-svg

Summit Therapeutics Inc. (SMMT)

summitplc-logo_05fd32df-svg

Summit Therapeutics Inc. (SMMT)

|||

Balance Sheets Overview

Current Ratio
695.77%
Quick Ratio
695.77%
Cash Ratio
404.93%
Debt to Asset Ratio
16.25%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Short-term investments
    • Prepaid expenses and other curre...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accrued liabilities
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
419,365
106,515
225,266
238,554
Restricted cash
317
316
316
321
Short-term investments
271,313
492,216
488,182
0
Prepaid expenses and other current assets
29,583
17,551
6,537
7,591
Total current assets
720,578
616,598
720,301
246,466
Property and equipment, net
1,781
1,664
1,059
810
Operating lease right-of-use assets
19,410
19,398
20,616
5,420
Goodwill
1,968
1,965
2,001
1,999
Other assets
8,448
8,231
7,205
7,034
Total assets
752,185
647,856
751,182
261,729
Accounts payable
22,896
27,549
20,292
22,245
Accrued liabilities
65,055
44,317
32,100
27,042
Accrued compensation
9,443
7,073
14,925
10,965
Operating lease liabilities, current portion
3,550
3,179
3,388
2,720
Other current liabilities
2,622
1,148
2,283
1,956
Total current liabilities
103,566
83,266
72,988
64,928
Operating lease liabilities, net of current portion
16,834
16,859
17,502
2,708
Other non-current liabilities
1,802
1,799
1,832
1,830
Total liabilities
122,202
101,924
92,322
69,466
Common stock, 0.01 par value 1,000,000,000 shares authorized 793,120,362 and 775,371,200 shares issued and outstanding at june 30, 2026 and december 31, 2025, respectively
7,931
7,760
7,754
7,444
Additional paid-in capital
3,324,000
3,024,387
2,947,805
2,262,515
Accumulated other comprehensive loss
-2,665
-2,632
-2,540
-2,709
Accumulated deficit
-2,699,283
-2,483,583
-2,294,159
-2,074,987
Total stockholders' equity
629,983
545,932
658,860
192,263
Total liabilities and stockholders' equity
752,185
647,856
751,182
261,729
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$419,365K (40.79%↑ Y/Y)Short-term investments$271,313K Prepaid expenses andother current assets$29,583K (167.74%↑ Y/Y)Restricted cash$317K (-0.63%↓ Y/Y)Total current assets$720,578K (133.02%↑ Y/Y)Operating leaseright-of-use assets$19,410K (249.60%↑ Y/Y)Other assets$8,448K (29.65%↑ Y/Y)Goodwill$1,968K (-3.48%↓ Y/Y)Property and equipment,net$1,781K (158.12%↑ Y/Y)Total assets$752,185K (132.13%↑ Y/Y)Total liabilities andstockholders' equity$752,185K (132.13%↑ Y/Y)Total stockholders'equity$629,983K (142.83%↑ Y/Y)Total liabilities$122,202K (89.17%↑ Y/Y)Accumulated deficit-$2,699,283K (-46.45%↓ Y/Y)Accumulated othercomprehensive loss-$2,665K (3.16%↑ Y/Y)Additional paid-in capital$3,324,000K (58.44%↑ Y/Y)Total currentliabilities$103,566K (71.68%↑ Y/Y)Operating leaseliabilities, net of current...$16,834K (591.33%↑ Y/Y)Other non-currentliabilities$1,802K (-1.96%↓ Y/Y)Common stock, 0.01 parvalue 1,000,000,000...$7,931K (6.77%↑ Y/Y)Accrued liabilities$65,055K (148.80%↑ Y/Y)Accounts payable$22,896K (-0.37%↓ Y/Y)Accrued compensation$9,443K (43.25%↑ Y/Y)Operating leaseliabilities, current portion$3,550K (13.86%↑ Y/Y)Other currentliabilities$2,622K (76.57%↑ Y/Y)